2021-06-01T05:56:56Z
2021-06-01T05:56:56Z
2021-01-01
2021-05-31T14:21:40Z
Rank signaling enhances stemness in mouse and human mammary epithelial cells (MECs) and mediates mammary tumor initiation. Mammary tumors initiated by oncogenes or carcinogen exposure display high levels of Rank and Rank pathway inhibitors have emerged as a new strategy for breast cancer prevention and treatment. Here, we show that ectopic Rank expression in the mammary epithelia unexpectedly delays tumor onset and reduces tumor incidence in the oncogene-driven Neu and PyMT models. Mechanistically, we have found that ectopic expression of Rank or exposure to Rankl induces senescence, even in the absence of other oncogenic mutations. Rank leads to DNA damage and senescence through p16/p19. Moreover, RANK-induced senescence is essential for Rank-driven stemness, and although initially translates into delayed tumor growth, eventually promotes tumor progression and metastasis. We uncover a dual role for Rank in the mammary epithelia: Rank induces senescence and stemness, delaying tumor initiation but increasing tumor aggressiveness.
Article
Published version
English
Càncer de mama; Metàstasi; Cicle cel·lular; Breast cancer; Metastasis; Cell cycle
Elsevier Inc.
Reproducció del document publicat a: https://doi.org/10.1016/j.devcel.2021.04.022
Developmental Cell, 2021, vol. 56
https://doi.org/10.1016/j.devcel.2021.04.022
info:eu-repo/grantAgreement/EC/H2020/682935/EU//PLEIO-RANK
cc by-nc-nd (c) Benítez et al., 2021
http://creativecommons.org/licenses/by-nc-nd/3.0/es/